Proteomics approaches to long COVID: status and outlooks

Xiao Liang, Yingrui Wang, Tiannan Guo

PDF(380 KB)
PDF(380 KB)
Life Medicine ›› 2023, Vol. 2 ›› Issue (3) : 4. DOI: 10.1093/lifemedi/lnad023
Research Highlight

Proteomics approaches to long COVID: status and outlooks

Author information +
History +

Cite this article

Download citation ▾
Xiao Liang, Yingrui Wang, Tiannan Guo. Proteomics approaches to long COVID: status and outlooks. Life Medicine, 2023, 2(3): 4 https://doi.org/10.1093/lifemedi/lnad023

References

[1]
Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Network Open 2021;4:e2128568.
CrossRef Google scholar
[2]
Soriano JB, Murthy S, Marshall JC, et al; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022;22:e102–7.
CrossRef Google scholar
[3]
Lu T, Wang Y, Guo T. Multi-omics in COVID-19: seeing the unseen but overlooked in the clinic. Cell Rep Med 2022;3:100580.
CrossRef Google scholar
[4]
Chen Y, Zhang N, Zhang J, et al. Immune response pattern across the asymptomatic, symptomatic and convalescent periods of COVID-19. Biochim Biophys Acta Proteins Proteom 2022;1870:140736.
CrossRef Google scholar
[5]
Pretorius E, Vlok M, Venter C, et al. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol 2021;20:172.
CrossRef Google scholar
[6]
Captur G, Moon JC, Topriceanu C-C, et al; UK COVIDsortium Investigators. Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection. EBioMedicine 2022;85:104293.
CrossRef Google scholar
[7]
Zhao J, Schank M, Wang L et al. Plasma biomarkers for systemic inflammation in COVID-19 survivors. Proteomics Clin Appl 2022;16:e2200031.
CrossRef Google scholar
[8]
Vijayakumar B, Boustani K, Ogger PP, et al. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity 2022;55:542–556.e5.
CrossRef Google scholar
[9]
Su Y, Yuan D, Chen DG, et al; ISB-Swedish COVID-19 Biobanking Unit. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 2022;185:881–895.e20.
[10]
Shen B, Yi X, Sun Y, et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell 2020;182:59–72.e15.
CrossRef Google scholar

RIGHTS & PERMISSIONS

2023 The Author(s) 2023. Published by Oxford University Press on behalf of Higher Education Press.
AI Summary AI Mindmap
PDF(380 KB)

Accesses

Citations

Detail

Sections
Recommended

/